logo

Tonix Pharmaceuticals Holding Corp. (TNXP)



Trade TNXP now with
  Date
  Headline
5/23/2022 11:04:10 AM Basler Shareholders Approve Agenda Items
5/18/2022 8:39:29 AM Tonix Pharma Extends Research Collaboration With University Of Alberta To Develop Antiviral Drugs Against SARS-CoV-2
5/9/2022 9:04:36 AM Tonix Pharma Q1 Loss Per Share $0.05 Vs Loss $0.07 Last Year
4/6/2022 7:56:13 AM Tonix Pharma Announces IND Clearance For TNX-102 SL As A Potential Treatment For Long COVID Syndrome
3/3/2022 7:14:54 AM Tonix Pharma: FDA Grants Orphan-Drug Designation For TNX-2900 For Prader-Willi Syndrome
11/23/2021 7:10:33 AM Tonix Pharma Announces FDA Clearance Of IND For TNX-1900 For Prevention Of Migraine Headache In Chronic Migraineurs
4/19/2021 7:09:48 AM Tonix Enters Exclusive Worldwide Licensing Agreement With OyaGen
3/15/2021 7:17:07 AM Tonix Pharma Achieves 50% Enrollment In RALLY; Sees Topline Results Of About 670 Participants In RALLY In Q4
1/5/2021 7:11:59 AM Tonix Pharma, MGH Enter Research Collaboration On TNX-1500 For The Treatment Of Kidney Transplant Rejection